-
1
-
-
0036021768
-
Indicaciones de la azatioprina (o 6-mercaptopurina) en la enfermedad inflamatoria intestinal
-
E. Cabré Indicaciones de la azatioprina (o 6-mercaptopurina) en la enfermedad inflamatoria intestinal Gastroenterol Hepatol 25 2006 319 326
-
(2006)
Gastroenterol Hepatol
, vol.25
, pp. 319-326
-
-
Cabré, E.1
-
3
-
-
0036022833
-
Preguntas y respuestas sobre el papel de la azatioprina y la 6-mercaptopurina en el tratamiento de la enfermedad inflamatoria intestinal
-
J.P. Gisbert F. Gomollón J. Mate J.M. Pajares Preguntas y respuestas sobre el papel de la azatioprina y la 6-mercaptopurina en el tratamiento de la enfermedad inflamatoria intestinal Gastroenterol Hepatol 25 2002 401 415
-
(2002)
Gastroenterol Hepatol
, vol.25
, pp. 401-415
-
-
Gisbert, J.P.1
Gomollón, F.2
Mate, J.3
Pajares, J.M.4
-
4
-
-
0029923360
-
A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate
-
W.J. Sandborn A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate Am J Gastroenterol 91 1996 423 434
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 423-434
-
-
Sandborn, W.J.1
-
5
-
-
20444483170
-
A randomized, double-blind, controlled withdrawal trial in Crohn’s disease patients in long-term remission with azathioprine
-
M. Lémann J.Y. Mary J.F. Colombel B. Duclos J.C. Soule E. Lerebours A randomized, double-blind, controlled withdrawal trial in Crohn’s disease patients in long-term remission with azathioprine Gastroenterology 128 2005 1812 1818
-
(2005)
Gastroenterology
, vol.128
, pp. 1812-1818
-
-
Lémann, M.1
Mary, J.Y.2
Colombel, J.F.3
Duclos, B.4
Soule, J.C.5
Lerebours, E.6
-
6
-
-
2942612097
-
Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn’s disease: increasing relapse rate the following year
-
M. Villien J.F. Dahlerup L.K. Munck P. Norregaard K. Gronbaek J. Fallingbrog Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn’s disease: increasing relapse rate the following year Aliment Pharmacol Ther 19 2004 1147 1152
-
(2004)
Aliment Pharmacol Ther
, vol.19
, pp. 1147-1152
-
-
Villien, M.1
Dahlerup, J.F.2
Munck, L.K.3
Norregaard, P.4
Gronbaek, K.5
Fallingbrog, J.6
-
7
-
-
0037254869
-
Infecciones oportunistas en pacientes con enfermedad inflamatoria intestinal bajo tratamiento inmunosupresor
-
I. Bernal E. Domènech E. García-Planella E. Cabré M.A. Gassull Infecciones oportunistas en pacientes con enfermedad inflamatoria intestinal bajo tratamiento inmunosupresor Gastroenterol Hepatol 26 2003 19 29
-
(2003)
Gastroenterol Hepatol
, vol.26
, pp. 19-29
-
-
Bernal, I.1
Domènech, E.2
García-Planella, E.3
Cabré, E.4
Gassull, M.A.5
-
8
-
-
0020540763
-
Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine
-
M.A. Epstein A.J. Morgan Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine Clin Exp Immunol 53 1983 257 271
-
(1983)
Clin Exp Immunol
, vol.53
, pp. 257-271
-
-
Epstein, M.A.1
Morgan, A.J.2
-
9
-
-
33746562435
-
Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
-
H. Kimura Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 16 2006 251 261
-
(2006)
Rev Med Virol
, vol.16
, pp. 251-261
-
-
Kimura, H.1
-
10
-
-
85119784863
-
-
Sandborn WJ, Sutherland L, Pearson D, May G, Modigliani R, Prantera C. Azatioprina o 6-mercaptopurina para la inducción de la remisión en la enfermedad de Crohn (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 1. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com (traducida de The Cochrane Library. Issue 1. Chichester: John Wiley & Sons, Ltd.; 2007).
-
-
-
-
11
-
-
85119777949
-
-
Pearson DC, May GR, Fick G, Sutherland LR. Azatioprina para el mantenimiento de la remisión en la enfermedad de Crohn (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 1. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com (traducida de The Cochrane Library. Issue 1. Chichester: John Wiley & Sons, Ltd.; 2007).
-
-
-
-
12
-
-
29244457275
-
Ramdomised, controlled trial, of azathioprine and 5-aminosalicylic acid for the treatment of steroid-dependent ulcerative colitis
-
S. Ardizzone G. Maconi A. Russo V. Imbesi E. Colombo G. Bianchi Porro Ramdomised, controlled trial, of azathioprine and 5-aminosalicylic acid for the treatment of steroid-dependent ulcerative colitis Gut 55 2006 47 53
-
(2006)
Gut
, vol.55
, pp. 47-53
-
-
Ardizzone, S.1
Maconi, G.2
Russo, A.3
Imbesi, V.4
Colombo, E.5
Bianchi Porro, G.6
-
13
-
-
0036909110
-
Azathioprine without oral cyclosporine in the long-term maintenance of remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis
-
E. Domènech E. García-Planella I. Bernal Azathioprine without oral cyclosporine in the long-term maintenance of remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis Aliment Ther Pharmacol 16 2002 2061 2065
-
(2002)
Aliment Ther Pharmacol
, vol.16
, pp. 2061-2065
-
-
Domènech, E.1
García-Planella, E.2
Bernal, I.3
-
14
-
-
0024457688
-
6-mercaptopurine in the management of the inflammatory bowel disease: short and long-term toxicity
-
D.H. Present S.J. Meltzer M.P. Krumholz A. Wolke B.I. Korelitz 6-mercaptopurine in the management of the inflammatory bowel disease: short and long-term toxicity Ann Int Med 111 1989 641 649
-
(1989)
Ann Int Med
, vol.111
, pp. 641-649
-
-
Present, D.H.1
Meltzer, S.J.2
Krumholz, M.P.3
Wolke, A.4
Korelitz, B.I.5
-
15
-
-
0036278519
-
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
-
A.G. Fraser T.R. Orchard D.P. Jewell The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review Gut 50 2002 485 489
-
(2002)
Gut
, vol.50
, pp. 485-489
-
-
Fraser, A.G.1
Orchard, T.R.2
Jewell, D.P.3
-
16
-
-
85119779914
-
-
Navarro Ortega D. Diagnóstico de la mononucleosis infecciosa causada por el virus de Epstein-Barr. Servicio de Microbiología. Hospital Clínico Universitario. Valencia. Control de Calidad de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Disponible en: http://www.seimc.org/control/revi_Sero/veb.htm
-
-
-
-
19
-
-
0038759014
-
Síndrome febril por infección por el virus del Epstein-Barr en la enfermedad de Crohn
-
B. Lobo B. Mínguez X. Molero F. Casellas Síndrome febril por infección por el virus del Epstein-Barr en la enfermedad de Crohn Med Clin (Barc) 120 2003 677 678
-
(2003)
Med Clin (Barc)
, vol.120
, pp. 677-678
-
-
Lobo, B.1
Mínguez, B.2
Molero, X.3
Casellas, F.4
-
20
-
-
33745545082
-
Reactive hemophagocytic syndrome complicating the treatment of inflammatory bowel disease
-
D.G. James C.D. Stone H.L. Wang W.F. Stenson Reactive hemophagocytic syndrome complicating the treatment of inflammatory bowel disease Inflamm Bowel Dis 12 2006 573 580
-
(2006)
Inflamm Bowel Dis
, vol.12
, pp. 573-580
-
-
James, D.G.1
Stone, C.D.2
Wang, H.L.3
Stenson, W.F.4
-
21
-
-
36049047688
-
Optimización del tratamiento inmunomodulador con azatioprina o 6-mercaptopurina en pacientes con enfermedad inflamatoria intestinal
-
G. Bastida P. Nos M. Aguas B. Beltrán M. Rodríguez J. Ponce Optimización del tratamiento inmunomodulador con azatioprina o 6-mercaptopurina en pacientes con enfermedad inflamatoria intestinal Gastroenterol Hepatol 30 2007 511 517
-
(2007)
Gastroenterol Hepatol
, vol.30
, pp. 511-517
-
-
Bastida, G.1
Nos, P.2
Aguas, M.3
Beltrán, B.4
Rodríguez, M.5
Ponce, J.6
-
22
-
-
0019814457
-
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and the role of Epstein-Barr virus
-
D.W. Hanto G. Frizzera D.T. Purtilo K. Sakamoo J.L. Sullivan A.K. Saemudsen Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and the role of Epstein-Barr virus Cancer Res 41 1981 4253 4261
-
(1981)
Cancer Res
, vol.41
, pp. 4253-4261
-
-
Hanto, D.W.1
Frizzera, G.2
Purtilo, D.T.3
Sakamoo, K.4
Sullivan, J.L.5
Saemudsen, A.K.6
-
23
-
-
0027310972
-
Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis
-
O.W. Kamel M. Van de Rijn L.M. Weiss G.J. Del Zoppo P.K. Hench B.A. Robbins Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis N Engl J Med 328 1993 1317 1321
-
(1993)
N Engl J Med
, vol.328
, pp. 1317-1321
-
-
Kamel, O.W.1
Van de Rijn, M.2
Weiss, L.M.3
Del Zoppo, G.J.4
Hench, P.K.5
Robbins, B.A.6
-
24
-
-
0033853911
-
Post-transplant malignancy: the role of immunosupression
-
I. Penn Post-transplant malignancy: the role of immunosupression Drug Saf 23 2000 101 113
-
(2000)
Drug Saf
, vol.23
, pp. 101-113
-
-
Penn, I.1
-
25
-
-
35349027343
-
Lymphoma risk in inflammatory bowel disease: is it the disease or its trreatment?
-
J.L. Jones E.V. Loftus Lymphoma risk in inflammatory bowel disease: is it the disease or its trreatment? Inflamm Bowel Dis 13 2007 1299 1307
-
(2007)
Inflamm Bowel Dis
, vol.13
, pp. 1299-1307
-
-
Jones, J.L.1
Loftus, E.V.2
-
27
-
-
0034913946
-
Review article: the risk of lymphoma associated to inflammatory bowel disease and immunosuppressive treatment
-
G.P. Aithal J.C. Mansfield Review article: the risk of lymphoma associated to inflammatory bowel disease and immunosuppressive treatment Aliment Pharmacol Ther 15 2001 1101 1108
-
(2001)
Aliment Pharmacol Ther
, vol.15
, pp. 1101-1108
-
-
Aithal, G.P.1
Mansfield, J.C.2
-
28
-
-
22644446331
-
Increased risk of lymphoma among inflammatory disease patients treated with azathioprine and 6-mercaptopurine
-
A. Kandiel A.G. Fraser B.I. Korelitz C. Brensinger C. Lewis J.D. Lewis Increased risk of lymphoma among inflammatory disease patients treated with azathioprine and 6-mercaptopurine Gut 54 2005 1121 1125
-
(2005)
Gut
, vol.54
, pp. 1121-1125
-
-
Kandiel, A.1
Fraser, A.G.2
Korelitz, B.I.3
Brensinger, C.4
Lewis, C.5
Lewis, J.D.6
-
31
-
-
0028147042
-
Reversible lymphoma in the setting of azathioprine therapy for Crohn’s disease
-
L. Larvol J.C. Soule A. Le Tourneau Reversible lymphoma in the setting of azathioprine therapy for Crohn’s disease N Engl J Med 331 1994 883 884
-
(1994)
N Engl J Med
, vol.331
, pp. 883-884
-
-
Larvol, L.1
Soule, J.C.2
Le Tourneau, A.3
-
32
-
-
0035097739
-
Primary Epstein-Barr virus-associated Hodgkin disease complicating of the ileum complicating Crohn disease
-
S. Li M.J. Borowitz Primary Epstein-Barr virus-associated Hodgkin disease complicating of the ileum complicating Crohn disease Arch Pathol Lab Med 125 2001 424 427
-
(2001)
Arch Pathol Lab Med
, vol.125
, pp. 424-427
-
-
Li, S.1
Borowitz, M.J.2
-
33
-
-
33644880019
-
Preemptive diagnosis and treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development
-
D.M. Weinstock G.C. Ambrossi C. Brennan T.E. Kiehn A. Jakubowski Preemptive diagnosis and treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development Bone Marrow Transpl 37 2006 539 546
-
(2006)
Bone Marrow Transpl
, vol.37
, pp. 539-546
-
-
Weinstock, D.M.1
Ambrossi, G.C.2
Brennan, C.3
Kiehn, T.E.4
Jakubowski, A.5
-
36
-
-
34447269692
-
Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients
-
M. Okano T.G. Gross Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients Expert Rev Anti Infect Ther 5 2007 403 413
-
(2007)
Expert Rev Anti Infect Ther
, vol.5
, pp. 403-413
-
-
Okano, M.1
Gross, T.G.2
-
37
-
-
31744433895
-
Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients
-
D.P. Funch A.M. Walker G. Schneider N.J. Ziyadeh M.D. Pescovitz Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients Am J Transplant 5 2005 2894 2900
-
(2005)
Am J Transplant
, vol.5
, pp. 2894-2900
-
-
Funch, D.P.1
Walker, A.M.2
Schneider, G.3
Ziyadeh, N.J.4
Pescovitz, M.D.5
-
38
-
-
0037097731
-
Prevention of Epstein-Barr virus lymphoprolifertaive disease by molecular monitoring and preemptive rituximab in high-risk patients after allogenic stem cell transplantation
-
J.W.J. Van Esser H.G.M. Niesters B. Van der Holt E. Meijer A.D.E. Osterhaus J.W. Gratama Prevention of Epstein-Barr virus lymphoprolifertaive disease by molecular monitoring and preemptive rituximab in high-risk patients after allogenic stem cell transplantation Blood 99 2002 4364 4369
-
(2002)
Blood
, vol.99
, pp. 4364-4369
-
-
Van Esser, J.W.J.1
Niesters, H.G.M.2
Van der Holt, B.3
Meijer, E.4
Osterhaus, A.D.E.5
Gratama, J.W.6
-
39
-
-
10844228164
-
Viral prophylaxis in organ transplant recipients
-
M. Slifkin S. Doran D.R. Snydman Viral prophylaxis in organ transplant recipients Drugs 64 2004 2763 2792
-
(2004)
Drugs
, vol.64
, pp. 2763-2792
-
-
Slifkin, M.1
Doran, S.2
Snydman, D.R.3
-
40
-
-
0038460251
-
Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma
-
J. Duraiswamy M. Sherritt S. Thomson J. Tellam L. Cooper G. Connoly Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma Blood 101 2003 3150 3156
-
(2003)
Blood
, vol.101
, pp. 3150-3156
-
-
Duraiswamy, J.1
Sherritt, M.2
Thomson, S.3
Tellam, J.4
Cooper, L.5
Connoly, G.6
|